Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
The Lancet. Gastroenterology & Hepatology|January 13, 2022
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trialSunil S Solomon, Sandra Wagner-Cardoso, Laura Smeaton, et al.
Viruses|January 25, 2025
COVID-19 and HIV: Clinical Outcomes and Inflammatory Markers in a Cohort from a Reference Hospital in Rio de Janeiro, BrazilNathalia Beatriz Ramos de Sá, Karine Venegas Macieira, Mariana Rosa Inacio Coelho, et al.
Vaccines|June 27, 2024
Impact of HIV-Related Immune Impairment of Yellow Fever Vaccine Immunogenicity in People Living with HIV-ANRS 12403Diogo Gama Caetano, Thais Stelzer Toledo, Ana Carolina Souza de Lima, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 27, 2025
A randomised trial to compare dolutegravir plus boosted darunavir versus recommended standard of care antiretroviral regimens in people with HIV-1, whose first-line non-nucleoside reverse transcriptase inhibitor therapy has failed: Final 96-week results of the D2EFT studyPhyo Pyae Nyein, Margaret Borok, Nnakelu Eriobu, et al.
BMC Infectious Diseases|October 8, 2025
Clinical outcomes of dolutegravir treatment in people living with HIV in Brazil: protocol for the CODE cohortCarlos Brites, Estela Luz, Cristiani Stelitano, et al.
AIDS (London, England)|August 9, 2024
Mpox, sexually transmitted infections and combination prevention: insights from a major cohort in Rio de Janeiro, BrazilMayara S T Silva, Thiago S Torres, Carolina Coutinho, et al.
Eclinicalmedicine|November 15, 2021
Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized TrialNiklaus D Labhardt, Mikaela Smit, Ianis Petignat, et al.
BMJ Open|February 5, 2026
Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trialAnthony L'hostellier, Charles Kouanfack, Corine Chazallon, et al.
Biomed Research International|September 15, 2022
Inflammasome Genetic Variants Are Associated with Protection to Clinical Severity of COVID-19 among Patients from Rio de Janeiro, BrazilNathalia Beatriz Ramos de Sá, Milena Neira-Goulart, Marcelo Ribeiro-Alves, et al.
AIDS Research and Therapy|February 25, 2022
Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP BrazilKarla Cristina Silva Petruccelli, Djane Clarys Baía-da-Silva, Fernando Val, et al.
Pageof 9